MYP_161213
Batifiban
Antiplatelet
GPIIb
IIIa antagonist
Standard
6 amino acids
C28H50N8O9S
Standard
NAMINI
674.81 Da
5.53
-0.24
-0.44
-0.0400
0.95
0.41
0.41
81.57
146.67
0.0000
0.00
0.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Amino Acid Composition
295.00
-2.56
9.0
10.0
22.0
46.0
0.0
7.0
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
RECORD: Rec_0149195
VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
disulfide-constrained cyclic peptide [Cyclic]
mixed L/D amino-acid peptide [Mixed]
None
None
1-6
Composite modified token aminoiminomethyl; Composite modified token mercapto; Composite modified token oxopropyl; Composite modified token trypotophyl; Composite modified token prolyl; Composite modified token disulfide
Bio-Activity Profile
Antiplatelet
GPIIb
IIIa antagonist
HPLC, MS-MS
Human blood plasma (Women) (Intravenous bolus followed by a continuous infusion of batifiban injection), in vivo; 11232 s